O

Ocular Therapeutix

D
OCUL
USD
-0.005
(-0.0552%)
Market Closed
75,164.00
Volume
-1.12
EPS
-
Div Yield
-8.302752
P/E
1,411,091,249.25
Market Cap
Today
-0.0552%
1 Week
3.904%
1 Month
3.547%
6 Months
-6.653%
12 Months
166.568%
Year To Date
102.915%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ALIM
-0.005
(-0.0902%)
USD
E
EYPT
0.281
(3.1612%)
USD
R
RETA
(%)
USD
REGN
REGN
11.33
(0.9948%)
USD
B
BTAI
0.0297
(4.661%)
USD
C
CRBP
2.21
(4.4646%)
USD
N
NTRA
-0.1
(-0.0787%)
USD
V
VKTX
3.72
(5.7692%)
USD
R
RGLS
0.08
(4.9383%)
USD

Title:
Ocular Therapeutix

Sector:
Healthcare
Industry:
Biotechnology
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Do you need help or have a question?
Contact Us